Author Roolf, Catrin

1 to 4 of 4 Items
  • 2016 Journal Article | 
    ​ ​Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells​
    Liu, W.; Beck, J.; Schmidt, L. C.; Roolf, C.; Pews-Davtyan, A.; Ruetgen, B. C. & Hammer, S. et al.​ (2016) 
    Oncotarget7(23) pp. 35379​-35389​.​ DOI: https://doi.org/10.18632/oncotarget.9297 
    Details  DOI  PMID  PMC  WoS 
  • 2018 Journal Article | 
    ​ ​Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation​
    Taher, L.; Beck, J.; Liu, W.; Roolf, C.; Soller, J. T.; Rütgen, B. C. & Hammer, S. E. et al.​ (2018) 
    Scientific Reports8(1).​ DOI: https://doi.org/10.1038/s41598-018-23207-7 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​PDA Indolylmaleimides Induce Anti-Tumor Effects in Prostate Carcinoma Cell Lines Through Mitotic Death​
    Schille, J. T.; Nolte, I.; Beck, J.; Jilani, D.; Roolf, C.; Pews-Davtyan, A. & Rolfs, A. et al.​ (2021) 
    Frontiers in Veterinary Science7.​ DOI: https://doi.org/10.3389/fvets.2020.558135 
    Details  DOI 
  • 2022 Journal Article | 
    ​ ​Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse​
    Gladbach, Y. S.; Sklarz, L.-M.; Roolf, C.; Beck, J.; Schütz, E. ; Fuellen, G. & Junghanss, C. et al.​ (2022) 
    Genes13(7) pp. 1240​.​ DOI: https://doi.org/10.3390/genes13071240 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page